Therapeutic Interchange Content Update Copied

In support of Therapeutic Interchange Management, the following TIC content groups will be available on Monday, May 4, 2026, in iKnowMed Generation 2:

  • Bevacizumab
  • Denosumab (Prolia)
  • Denosumab (Xgeva)
  • Eculizumab
  • Epoetin alfa
  • Filgrastim
  • Infliximab IV
  • Pegfilgrastim
  • Rituximab IV
  • Tocilizumab IV
  • Tocilizumab SQ
  • Trastuzumab IV